Global RNA Targeting Small Molecule Drug Discovery Market Size study & Forecast, by Indication (Cancer, Infectious Diseases, Metabolic Diseases, Neurological Diseases, Other), by End User (Pharmaceutical and Biopharmaceutical Companies, Academic and Research Institutes, Other) and Regional Analysis, 2023-2030
Global RNA Targeting Small Molecule Drug Discovery Market is valued at approximately USD 1.1 billion in 2022 and is anticipated to grow with a compounded annual growth rate of more than 20.9% over the forecast period 2023-2030. RNA targeting small molecules drug discovery refers to the process of identifying and developing small molecule drugs that specifically target and modulate the activity of RNA molecules within cells. RNA, or ribonucleic acid, plays a crucial role in various cellular processes, including gene expression and regulation. A small molecule is an organic compound with a relatively low, molecular weight that can interact with biological targets such as proteins or nucleic acids. Thus, increasing research and development (R&D) investment and Advancement in RNA Biology are anticipated to elevate the growth of the Global RNA Targeting Small Molecule Drug Discovery Market.
According to the International Agency for Research on Cancer (IARC) in 2018, the global incidence of cancer was approximately 17 million new cases and resulted in 9.5 million cancer related deaths. It is projected that, by 2040, these numbers are anticipated to rise to 27.5 million new cancer cases and 16.3 million cancer related deaths due to population growth and ageing alone. Moreover, the future burden is expected to be even greater as a consequence of escalating risk factors such as smoking, unhealthy diet, physical inactivity, and declining childbirth rates in economically transitioning nations. According to World Bank in 2020, Governments typically allocated just over 2% of their total health budgets to mental health expenses on average. Additionally, many low-income countries reported having fewer than one mental health worker for one lakh individuals. Recognizing the importance of mental health as a significant component of global health and human capital development, the World Bank is actively supporting initiatives to prioritize and integrate mental health services on a global scale which is driving the demand for the RNA Targeting Small Molecule Drug Discovery Market. However, cost, time and delivery challenges may hamper the growth of the Global RNA Targeting Small Molecule Drug Discovery Market. Moreover, government initiatives & regulatory support and high unmet medical needs emerge as some of the growth opportunities for the market.
The key regions considered for the Global RNA Targeting Small Molecule Drug Discovery Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the dominance of branded products and the region's increasing prevalence of diseases. The CDC expected that in 2020, the United States may have approximately 37.3 million individuals with diabetes. This includes 28.7 million diagnosed cases and 8.5 million undiagnosed cases, as diabetes has a genetic basis. The Asia Pacific region is anticipated to experience substantial growth in the forecast period due to factors such as a growing elderly population, increasing target populations, greater collaboration for biosimilar development, expansion of key players into new geographic areas, and active involvement of government and nonprofit organizations in the market.
Major market player included in this report are:
Accent TherapeuticsInc.
Anima Biotech Inc.
AstraZeenca
Epics Therapeutics
Expansion Therapeutics
F.Hoffmann-La Roche Ltd.
H3 Biomedicine Inc.
PTC Therapeutics Inc.
Ribometrix Inc.
Skyhawk Therapeutics Inc.
Recent Developments in the Market:
In January 2023, biotechnology company Businesswire a Berkshire Hathaway Company introduces an innovative RNA structure platform powered by artificial intelligence to address diseases that are currently difficult to treat. The platform utilizes an AI-driven 3-D RNA structure engine to generate a comprehensive data site of RNA structures. By integrating this dataset with machine learning foundation models and extensive in-house experimental wet-lab biology, the platform revolutionizes the field of RNA drug discovery opening new possibilities for the development of RNA-targeted therapies.
In February 2023, ReviR Therapeutics Inc. partnered with Asieris Pharmaceuticals Co. Ltd. To develop new oncology therapies.
Global RNA Targeting Small Molecule Drug Discovery Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Indication, End User, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Indication:
Cancer
Infectious Diseases
Metabolic Diseases
Neurological Diseases
Other
By End User:
Pharmaceuticals & Biopharmaceuticals Companies
Academic & Research Institutes
Other
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
According to the International Agency for Research on Cancer (IARC) in 2018, the global incidence of cancer was approximately 17 million new cases and resulted in 9.5 million cancer related deaths. It is projected that, by 2040, these numbers are anticipated to rise to 27.5 million new cancer cases and 16.3 million cancer related deaths due to population growth and ageing alone. Moreover, the future burden is expected to be even greater as a consequence of escalating risk factors such as smoking, unhealthy diet, physical inactivity, and declining childbirth rates in economically transitioning nations. According to World Bank in 2020, Governments typically allocated just over 2% of their total health budgets to mental health expenses on average. Additionally, many low-income countries reported having fewer than one mental health worker for one lakh individuals. Recognizing the importance of mental health as a significant component of global health and human capital development, the World Bank is actively supporting initiatives to prioritize and integrate mental health services on a global scale which is driving the demand for the RNA Targeting Small Molecule Drug Discovery Market. However, cost, time and delivery challenges may hamper the growth of the Global RNA Targeting Small Molecule Drug Discovery Market. Moreover, government initiatives & regulatory support and high unmet medical needs emerge as some of the growth opportunities for the market.
The key regions considered for the Global RNA Targeting Small Molecule Drug Discovery Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the dominance of branded products and the region's increasing prevalence of diseases. The CDC expected that in 2020, the United States may have approximately 37.3 million individuals with diabetes. This includes 28.7 million diagnosed cases and 8.5 million undiagnosed cases, as diabetes has a genetic basis. The Asia Pacific region is anticipated to experience substantial growth in the forecast period due to factors such as a growing elderly population, increasing target populations, greater collaboration for biosimilar development, expansion of key players into new geographic areas, and active involvement of government and nonprofit organizations in the market.
Major market player included in this report are:
Accent TherapeuticsInc.
Anima Biotech Inc.
AstraZeenca
Epics Therapeutics
Expansion Therapeutics
F.Hoffmann-La Roche Ltd.
H3 Biomedicine Inc.
PTC Therapeutics Inc.
Ribometrix Inc.
Skyhawk Therapeutics Inc.
Recent Developments in the Market:
In January 2023, biotechnology company Businesswire a Berkshire Hathaway Company introduces an innovative RNA structure platform powered by artificial intelligence to address diseases that are currently difficult to treat. The platform utilizes an AI-driven 3-D RNA structure engine to generate a comprehensive data site of RNA structures. By integrating this dataset with machine learning foundation models and extensive in-house experimental wet-lab biology, the platform revolutionizes the field of RNA drug discovery opening new possibilities for the development of RNA-targeted therapies.
In February 2023, ReviR Therapeutics Inc. partnered with Asieris Pharmaceuticals Co. Ltd. To develop new oncology therapies.
Global RNA Targeting Small Molecule Drug Discovery Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Indication, End User, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Indication:
Cancer
Infectious Diseases
Metabolic Diseases
Neurological Diseases
Other
By End User:
Pharmaceuticals & Biopharmaceuticals Companies
Academic & Research Institutes
Other
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. RNA Targeting Small Molecule Drug Discovery Market, by Region, 2020-2030 (USD Billion)
1.2.2. RNA Targeting Small Molecule Drug Discovery Market, by Indication, 2020-2030 (USD Billion)
1.2.3. RNA Targeting Small Molecule Drug Discovery Market, by End User, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL RNA TARGETING SMALL MOLECULE DRUG DISCOVERY MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL RNA TARGETING SMALL MOLECULE DRUG DISCOVERY MARKET DYNAMICS
3.1. RNA Targeting Small Molecule Drug Discovery Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing Research and Development (R&D) Investment
3.1.1.2. Advancement in RNA Biology
3.1.2. Market Challenges
3.1.2.1. High Cost and Time
3.1.2.2. High Delivery Challenges
3.1.3. Market Opportunities
3.1.3.1. Government Initiatives & Regulatory Support
3.1.3.2. High demand for Medical Need
CHAPTER 4. GLOBAL RNA TARGETING SMALL MOLECULE DRUG DISCOVERY MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL RNA TARGETING SMALL MOLECULE DRUG DISCOVERY MARKET, BY INDICATION
5.1. Market Snapshot
5.2. Global RNA Targeting Small Molecule Drug Discovery Market by Indication, Performance - Potential Analysis
5.3. Global RNA Targeting Small Molecule Drug Discovery Market Estimates & Forecasts by Indication 2020-2030 (USD Billion)
5.4. RNA Targeting Small Molecule Drug Discovery Market, Sub Segment Analysis
5.4.1. Cancer
5.4.2. Infectious Diseases
5.4.3. Metabolic Diseases
5.4.4. Neurological Diseases
5.4.5. Other
CHAPTER 6. GLOBAL RNA TARGETING SMALL MOLECULE DRUG DISCOVERY MARKET, BY END USER
6.1. Market Snapshot
6.2. Global RNA Targeting Small Molecule Drug Discovery Market by End User, Performance - Potential Analysis
6.3. Global RNA Targeting Small Molecule Drug Discovery Market Estimates & Forecasts by End User 2020-2030 (USD Billion)
6.4. RNA Targeting Small Molecule Drug Discovery Market, Sub Segment Analysis
6.4.1. Pharmaceuticals & Biopharmaceuticals Companies
6.4.2. Academic and Research Institutes
6.4.3. Other
CHAPTER 7. GLOBAL RNA TARGETING SMALL MOLECULE DRUG DISCOVERY MARKET, REGIONAL ANALYSIS
7.1. Top Leading Countries
7.2. Top Emerging Countries
7.3. RNA Targeting Small Molecule Drug Discovery Market, Regional Market Snapshot
7.4. North America RNA Targeting Small Molecule Drug Discovery Market
7.4.1. U.S. RNA Targeting Small Molecule Drug Discovery Market
7.4.1.1. Indication breakdown estimates & forecasts, 2020-2030
7.4.1.2. End User breakdown estimates & forecasts, 2020-2030
7.4.2. Canada RNA Targeting Small Molecule Drug Discovery Market
7.5. Europe RNA Targeting Small Molecule Drug Discovery Market Snapshot
7.5.1. U.K. RNA Targeting Small Molecule Drug Discovery Market
7.5.2. Germany RNA Targeting Small Molecule Drug Discovery Market
7.5.3. France RNA Targeting Small Molecule Drug Discovery Market
7.5.4. Spain RNA Targeting Small Molecule Drug Discovery Market
7.5.5. Italy RNA Targeting Small Molecule Drug Discovery Market
7.5.6. Rest of Europe RNA Targeting Small Molecule Drug Discovery Market
7.6. Asia-Pacific RNA Targeting Small Molecule Drug Discovery Market Snapshot
7.6.1. China RNA Targeting Small Molecule Drug Discovery Market
7.6.2. India RNA Targeting Small Molecule Drug Discovery Market
7.6.3. Japan RNA Targeting Small Molecule Drug Discovery Market
7.6.4. Australia RNA Targeting Small Molecule Drug Discovery Market
7.6.5. South Korea RNA Targeting Small Molecule Drug Discovery Market
7.6.6. Rest of Asia Pacific RNA Targeting Small Molecule Drug Discovery Market
7.7. Latin America RNA Targeting Small Molecule Drug Discovery Market Snapshot
7.7.1. Brazil RNA Targeting Small Molecule Drug Discovery Market
7.7.2. Mexico RNA Targeting Small Molecule Drug Discovery Market
7.8. Middle East & Africa RNA Targeting Small Molecule Drug Discovery Market
7.8.1. Saudi Arabia RNA Targeting Small Molecule Drug Discovery Market
7.8.2. South Africa RNA Targeting Small Molecule Drug Discovery Market
7.8.3. Rest of Middle East & Africa RNA Targeting Small Molecule Drug Discovery Market
CHAPTER 8. COMPETITIVE INTELLIGENCE
8.1. Key Company SWOT Analysis
8.1.1. Company
8.1.2. Company
8.1.3. Company
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Accent Therapeutics Inc.
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Recent Developments
8.3.2. Anima Biotech Inc.
8.3.3. AstraZeneca
8.3.4. Epics Therapeutics
8.3.5. Expansion Therapeutics
8.3.6. F.Hoffmann-La Roche Ltd.
8.3.7. H3 Biomedicine Inc.
8.3.8. PTC Therapeutics Inc.
8.3.9. Ribometrix Inc.
8.3.10. Skyhawk Therapeutics Inc.
CHAPTER 9. RESEARCH PROCESS
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. RNA Targeting Small Molecule Drug Discovery Market, by Region, 2020-2030 (USD Billion)
1.2.2. RNA Targeting Small Molecule Drug Discovery Market, by Indication, 2020-2030 (USD Billion)
1.2.3. RNA Targeting Small Molecule Drug Discovery Market, by End User, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL RNA TARGETING SMALL MOLECULE DRUG DISCOVERY MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL RNA TARGETING SMALL MOLECULE DRUG DISCOVERY MARKET DYNAMICS
3.1. RNA Targeting Small Molecule Drug Discovery Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing Research and Development (R&D) Investment
3.1.1.2. Advancement in RNA Biology
3.1.2. Market Challenges
3.1.2.1. High Cost and Time
3.1.2.2. High Delivery Challenges
3.1.3. Market Opportunities
3.1.3.1. Government Initiatives & Regulatory Support
3.1.3.2. High demand for Medical Need
CHAPTER 4. GLOBAL RNA TARGETING SMALL MOLECULE DRUG DISCOVERY MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL RNA TARGETING SMALL MOLECULE DRUG DISCOVERY MARKET, BY INDICATION
5.1. Market Snapshot
5.2. Global RNA Targeting Small Molecule Drug Discovery Market by Indication, Performance - Potential Analysis
5.3. Global RNA Targeting Small Molecule Drug Discovery Market Estimates & Forecasts by Indication 2020-2030 (USD Billion)
5.4. RNA Targeting Small Molecule Drug Discovery Market, Sub Segment Analysis
5.4.1. Cancer
5.4.2. Infectious Diseases
5.4.3. Metabolic Diseases
5.4.4. Neurological Diseases
5.4.5. Other
CHAPTER 6. GLOBAL RNA TARGETING SMALL MOLECULE DRUG DISCOVERY MARKET, BY END USER
6.1. Market Snapshot
6.2. Global RNA Targeting Small Molecule Drug Discovery Market by End User, Performance - Potential Analysis
6.3. Global RNA Targeting Small Molecule Drug Discovery Market Estimates & Forecasts by End User 2020-2030 (USD Billion)
6.4. RNA Targeting Small Molecule Drug Discovery Market, Sub Segment Analysis
6.4.1. Pharmaceuticals & Biopharmaceuticals Companies
6.4.2. Academic and Research Institutes
6.4.3. Other
CHAPTER 7. GLOBAL RNA TARGETING SMALL MOLECULE DRUG DISCOVERY MARKET, REGIONAL ANALYSIS
7.1. Top Leading Countries
7.2. Top Emerging Countries
7.3. RNA Targeting Small Molecule Drug Discovery Market, Regional Market Snapshot
7.4. North America RNA Targeting Small Molecule Drug Discovery Market
7.4.1. U.S. RNA Targeting Small Molecule Drug Discovery Market
7.4.1.1. Indication breakdown estimates & forecasts, 2020-2030
7.4.1.2. End User breakdown estimates & forecasts, 2020-2030
7.4.2. Canada RNA Targeting Small Molecule Drug Discovery Market
7.5. Europe RNA Targeting Small Molecule Drug Discovery Market Snapshot
7.5.1. U.K. RNA Targeting Small Molecule Drug Discovery Market
7.5.2. Germany RNA Targeting Small Molecule Drug Discovery Market
7.5.3. France RNA Targeting Small Molecule Drug Discovery Market
7.5.4. Spain RNA Targeting Small Molecule Drug Discovery Market
7.5.5. Italy RNA Targeting Small Molecule Drug Discovery Market
7.5.6. Rest of Europe RNA Targeting Small Molecule Drug Discovery Market
7.6. Asia-Pacific RNA Targeting Small Molecule Drug Discovery Market Snapshot
7.6.1. China RNA Targeting Small Molecule Drug Discovery Market
7.6.2. India RNA Targeting Small Molecule Drug Discovery Market
7.6.3. Japan RNA Targeting Small Molecule Drug Discovery Market
7.6.4. Australia RNA Targeting Small Molecule Drug Discovery Market
7.6.5. South Korea RNA Targeting Small Molecule Drug Discovery Market
7.6.6. Rest of Asia Pacific RNA Targeting Small Molecule Drug Discovery Market
7.7. Latin America RNA Targeting Small Molecule Drug Discovery Market Snapshot
7.7.1. Brazil RNA Targeting Small Molecule Drug Discovery Market
7.7.2. Mexico RNA Targeting Small Molecule Drug Discovery Market
7.8. Middle East & Africa RNA Targeting Small Molecule Drug Discovery Market
7.8.1. Saudi Arabia RNA Targeting Small Molecule Drug Discovery Market
7.8.2. South Africa RNA Targeting Small Molecule Drug Discovery Market
7.8.3. Rest of Middle East & Africa RNA Targeting Small Molecule Drug Discovery Market
CHAPTER 8. COMPETITIVE INTELLIGENCE
8.1. Key Company SWOT Analysis
8.1.1. Company
8.1.2. Company
8.1.3. Company
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Accent Therapeutics Inc.
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Recent Developments
8.3.2. Anima Biotech Inc.
8.3.3. AstraZeneca
8.3.4. Epics Therapeutics
8.3.5. Expansion Therapeutics
8.3.6. F.Hoffmann-La Roche Ltd.
8.3.7. H3 Biomedicine Inc.
8.3.8. PTC Therapeutics Inc.
8.3.9. Ribometrix Inc.
8.3.10. Skyhawk Therapeutics Inc.
CHAPTER 9. RESEARCH PROCESS
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
LIST OF TABLES
TABLE 1. Global RNA Targeting Small Molecule Drug Discovery Market, report scope
TABLE 2. Global RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by Indication 2020-2030 (USD Billion)
TABLE 4. Global RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by End User 2020-2030 (USD Billion)
TABLE 5. Global RNA Targeting Small Molecule Drug Discovery Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 6. Global RNA Targeting Small Molecule Drug Discovery Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global RNA Targeting Small Molecule Drug Discovery Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global RNA Targeting Small Molecule Drug Discovery Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global RNA Targeting Small Molecule Drug Discovery Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global RNA Targeting Small Molecule Drug Discovery Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global RNA Targeting Small Molecule Drug Discovery Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global RNA Targeting Small Molecule Drug Discovery Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global RNA Targeting Small Molecule Drug Discovery Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global RNA Targeting Small Molecule Drug Discovery Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. U.S. RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 17. U.S. RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. Canada RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 19. Canada RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 20. Canada RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. UK RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 22. UK RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 23. UK RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. Germany RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 25. Germany RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 26. Germany RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. France RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 28. France RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 29. France RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. Italy RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 31. Italy RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 32. Italy RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Spain RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 34. Spain RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 35. Spain RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. RoE RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 37. RoE RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 38. RoE RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. China RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 40. China RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 41. China RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. India RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 43. India RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 44. India RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. Japan RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 46. Japan RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 47. Japan RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. South Korea RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 49. South Korea RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 50. South Korea RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. Australia RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 52. Australia RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 53. Australia RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. RoAPAC RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 55. RoAPAC RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 56. RoAPAC RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. Brazil RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 58. Brazil RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 59. Brazil RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Mexico RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 61. Mexico RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 62. Mexico RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. RoLA RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 64. RoLA RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 65. RoLA RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. Saudi Arabia RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 67. South Africa RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 68. RoMEA RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global RNA Targeting Small Molecule Drug Discovery Market
TABLE 70. List of primary sources, used in the study of global RNA Targeting Small Molecule Drug Discovery Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures are dummy in nature, final lists may vary in the final deliverable
TABLE 1. Global RNA Targeting Small Molecule Drug Discovery Market, report scope
TABLE 2. Global RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by Indication 2020-2030 (USD Billion)
TABLE 4. Global RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by End User 2020-2030 (USD Billion)
TABLE 5. Global RNA Targeting Small Molecule Drug Discovery Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 6. Global RNA Targeting Small Molecule Drug Discovery Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global RNA Targeting Small Molecule Drug Discovery Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global RNA Targeting Small Molecule Drug Discovery Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global RNA Targeting Small Molecule Drug Discovery Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global RNA Targeting Small Molecule Drug Discovery Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global RNA Targeting Small Molecule Drug Discovery Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global RNA Targeting Small Molecule Drug Discovery Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global RNA Targeting Small Molecule Drug Discovery Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global RNA Targeting Small Molecule Drug Discovery Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. U.S. RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 17. U.S. RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. Canada RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 19. Canada RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 20. Canada RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. UK RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 22. UK RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 23. UK RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. Germany RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 25. Germany RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 26. Germany RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. France RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 28. France RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 29. France RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. Italy RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 31. Italy RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 32. Italy RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Spain RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 34. Spain RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 35. Spain RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. RoE RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 37. RoE RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 38. RoE RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. China RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 40. China RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 41. China RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. India RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 43. India RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 44. India RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. Japan RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 46. Japan RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 47. Japan RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. South Korea RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 49. South Korea RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 50. South Korea RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. Australia RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 52. Australia RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 53. Australia RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. RoAPAC RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 55. RoAPAC RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 56. RoAPAC RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. Brazil RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 58. Brazil RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 59. Brazil RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Mexico RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 61. Mexico RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 62. Mexico RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. RoLA RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 64. RoLA RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 65. RoLA RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. Saudi Arabia RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 67. South Africa RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 68. RoMEA RNA Targeting Small Molecule Drug Discovery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global RNA Targeting Small Molecule Drug Discovery Market
TABLE 70. List of primary sources, used in the study of global RNA Targeting Small Molecule Drug Discovery Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures are dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global RNA Targeting Small Molecule Drug Discovery Market, research methodology
FIG 2. Global RNA Targeting Small Molecule Drug Discovery Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global RNA Targeting Small Molecule Drug Discovery Market, key trends 2022
FIG 5. Global RNA Targeting Small Molecule Drug Discovery Market, growth prospects 2023-2030
FIG 6. Global RNA Targeting Small Molecule Drug Discovery Market, porters 5 force model
FIG 7. Global RNA Targeting Small Molecule Drug Discovery Market, pest analysis
FIG 8. Global RNA Targeting Small Molecule Drug Discovery Market, value chain analysis
FIG 9. Global RNA Targeting Small Molecule Drug Discovery Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global RNA Targeting Small Molecule Drug Discovery Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global RNA Targeting Small Molecule Drug Discovery Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global RNA Targeting Small Molecule Drug Discovery Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global RNA Targeting Small Molecule Drug Discovery Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global RNA Targeting Small Molecule Drug Discovery Market, regional snapshot 2020 & 2030
FIG 15. North America RNA Targeting Small Molecule Drug Discovery Market 2020 & 2030 (USD Billion)
FIG 16. Europe RNA Targeting Small Molecule Drug Discovery Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific RNA Targeting Small Molecule Drug Discovery Market 2020 & 2030 (USD Billion)
FIG 18. Latin America RNA Targeting Small Molecule Drug Discovery Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa RNA Targeting Small Molecule Drug Discovery Market 2020 & 2030 (USD Billion)
List of tables and figures are dummy in nature, final lists may vary in the final deliverable
FIG 1. Global RNA Targeting Small Molecule Drug Discovery Market, research methodology
FIG 2. Global RNA Targeting Small Molecule Drug Discovery Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global RNA Targeting Small Molecule Drug Discovery Market, key trends 2022
FIG 5. Global RNA Targeting Small Molecule Drug Discovery Market, growth prospects 2023-2030
FIG 6. Global RNA Targeting Small Molecule Drug Discovery Market, porters 5 force model
FIG 7. Global RNA Targeting Small Molecule Drug Discovery Market, pest analysis
FIG 8. Global RNA Targeting Small Molecule Drug Discovery Market, value chain analysis
FIG 9. Global RNA Targeting Small Molecule Drug Discovery Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global RNA Targeting Small Molecule Drug Discovery Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global RNA Targeting Small Molecule Drug Discovery Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global RNA Targeting Small Molecule Drug Discovery Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global RNA Targeting Small Molecule Drug Discovery Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global RNA Targeting Small Molecule Drug Discovery Market, regional snapshot 2020 & 2030
FIG 15. North America RNA Targeting Small Molecule Drug Discovery Market 2020 & 2030 (USD Billion)
FIG 16. Europe RNA Targeting Small Molecule Drug Discovery Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific RNA Targeting Small Molecule Drug Discovery Market 2020 & 2030 (USD Billion)
FIG 18. Latin America RNA Targeting Small Molecule Drug Discovery Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa RNA Targeting Small Molecule Drug Discovery Market 2020 & 2030 (USD Billion)
List of tables and figures are dummy in nature, final lists may vary in the final deliverable
